BSP Pharmaceuticals is proud to announce Its participation to the 13th European edition of World ADC Summit.
World ADC Summit of London covers cutting edge science and transformative insight enabling the companies to more clinically safe and efficacious ADCs. The 13th World ADC London is the meeting for leading biopharma and academic experts to access the latest and hottest ADC news across all levels of drug development. This summit delves deeper into the exciting clinical progress of ADCs in combination therapies, next-generation novel formats, and optimising both early and late-stage manufacturing processes.
During this edition of the Summit, various Pharmaceutical companies will present their new scientifically novels on ADC research and openly talking about their experiences on how to validate the next generation of tumor associated antigens, harness preclinical learning to confidently translate into the clinic and confidently scale up from phase II to phase III manufacturing.
This event unite 400+ leading players in the ADC field to ensure the most pressing challenges faced by the community are covered and accelerate the delivery of viable and life-changing therapeutics to oncology patients.
Save the Date!!! Next Tuesday, 14th of March, our Giorgio Salciarini – Marketing & Development Business Manager – will present its speech: Addressing the Complexity of Manufatcuring ADCs from Early stage to Commercial during the Conference Day1, starting from 17:45 PM
To request a meeting and for any info, You can send an e-mail at Business.Development@Bsppharmaceuticals.com